Adam Levy

Investor Relations Contact at ALAUNOS THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Adam D.
Levy is currently the Executive Director-Investor Relations at Gilead Sciences, Inc., the Director at Vesselon, Inc., the Senior VP-Communications & Investor Relations at Turning Point Therapeutics, Inc., the EVP-Corporate Development & Investor Relations at Alaunos Therapeutics, Inc., and the SVP, Head-Investor Relations & Corporate Affairs at Acrivon Therapeutics, Inc. Previously, he worked as the Senior Vice President-Investor Relations at Zentalis Pharmaceuticals, Inc. Dr. Levy completed his undergraduate and doctorate degrees at the University of Illinois and holds an MBA from the Kellogg School of Management.

Adam Levy active positions

Companies	Position	Start
ALAUNOS THERAPEUTICS, INC.	Investor Relations Contact	31/10/2020
TURG POIN	Investor Relations Contact	07/11/2021
GILEAD SCIENCES, INC.	Corporate Officer/Principal	-
ACRIVON THERAPEUTICS, INC.	Investor Relations Contact	19/07/2023
Vesselon, Inc. Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT.	Director/Board Member	-

All active positions of Adam Levy

Former positions of Adam Levy

Companies	Position	End
ZENTALIS PHARMACEUTICALS, INC.	Investor Relations Contact	-

See the detail of Adam Levy's experience

Training of Adam Levy

University of Illinois	Doctorate Degree
Kellogg School of Management	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adam Levy's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	4
GILEAD SCIENCES, INC.	Health Technology
ALAUNOS THERAPEUTICS, INC.	Health Technology
ZENTALIS PHARMACEUTICALS, INC.	Health Technology
ACRIVON THERAPEUTICS, INC.	Health Technology

Private companies	2
Turning Point Therapeutics, Inc. Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.	Health Technology
Vesselon, Inc. Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT.	Health Technology